ACHE and Parkinson disease: Furthermore, the study of AChE inhibition may be crucial in neurodegenerative disease research, because the dysfunction of this enzyme disturbs the cholinergic neurotransmission (i.e., involving neurotransmitter acetylcholine), which is related to the pathogenesis of neurodegenerative disorders such as Parkinson’s disease (PD).